Loading provider…
Loading provider…
Ophthalmology Physician in Rancho Cordova, CA
NPI: 1063439776Primary Practice Location
Martel Eye Medical Group
11216 Trinity River Dr, Rancho Cordova, CA
Primary Employer
Martel Eye Medical Group
martelmd.com
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1982 - 2026
CO State Medical License
1980 - 1987

American Board of Ophthalmology
Ophthalmology
University of Wisconsin–Madison
med.wisc.edu
Medical School
Until 1978
University of Colorado
Residency • Ophthalmology
1979 - 1982
San Joaquin General Hospital
Internship • Internal Medicine
1978 - 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 221 | 243 |
| 2 | 92250Photography of the retina | 183 | 203 |
| 3 | 76519Ultrasound of eye for determination of lens power | 168 | 191 |
| 4 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 152 | 166 |
| 5 | 66984Removal of cataract with insertion of lens | 102 | 111 |
'OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain
Authors: Michael Korenfeld, Joe Gira, Tom Walters, Dale Usner, Eric Donnenfeld, Kevin
Publication Date: 2022-12
Authors: John Goosey, Joseph Martel, Sherif El-Harazi, William Lipsky, David Wirta
Journal: BMC Ophthalmol
Publication Date: 2024-07-17
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: 0.02% Betamethasone Sodium Phosphate, DRUG: 0.04% Betamethasone Sodium Phosphate
Lead Sponsor: Kala Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Vehicle of KPI-121 0.25% Ophthalmic Suspension, DRUG: KPI-121 0.25% Ophthalmic Suspension